TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive IARC Finds Limited Evidence That Residential Magnetic Fields Raise Leukemia Risk. June 29, 2001